Interestingly, recent study demonstrated the ability of phosphorylated tau to disrupt V-type proton ATPase function through its interaction with the ATP6V1B2 subunit [140], which was associated with phospho-tau lesions in all 4 studied tauopathies. Here, MAPT is linked to tauopathy.